MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings. The new ...

Outside of browsers rehype-mermaid uses Playwright. If you use this outside of a browser, you need to install Playwright and a Playwright browser.

One IR to map them all. Erdus is the open-source universal converter for ER diagrams and database schemas. It unifies ERDPlus, SQL DDL, Prisma, TypeORM, JSON Schema and more under a strict ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Senior Food and Drug Administration official Vinay Prasad has reclaimed a role as the agency’s top doctor and scientist six weeks after his dramatic departure and one month after his surprising return ...

Novo Nordisk and Eli Lilly have established a commanding lead in obesity with their drugs Wegovy and Zepbound, with each recording sales of nearly $6 billion through the first six months of 2025.

US pharmaceutical giant Merck is scrapping a planned £1bn expansion of its UK operations, saying the government is not investing enough in the sector. The multi-national business, known as MSD in ...

Only show cars that can be delivered to me. Please enter your postal code in order to show cars that can be delivered to you.